白质高强度在患有Lewy体和后皮层缩的痴呆症中的白质
Neha Singh-Reilly1, Nha Trang Thu Pham2, Jonathan Graff-Radford1
1Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Neurobiology of aging
|March 8, 2025
概括
勒维体痴呆症 (DLB) 和后皮层缩 (PCA) 显示出明显的白质强度过高 (WMH) 模式. PCA表现出更多的皮下WMH,而DLB显示出更多的状WMH,表明不同的疾病机制.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 放射学 放射学是一门学科.
背景情况:
- 勒维体痴呆 (DLB) 和后皮层缩 (PCA) 是具有重叠特征的神经退行性疾病.
- 了解DLB中的特定白质超强度 (WMH) 负担,特别是没有阿尔茨海默病 (AD) 病理,对于差异诊断至关重要.
- 区域性WMH模式可能有助于区分DLB和PCA,表明不同的潜在病理生理过程.
研究的目的:
- 调查和比较区域白质强度过高 (WMH) 负担在粉素阴性痴呆症与勒维体 (DLB) 患者与粉素阳性后皮层缩 (PCA) 患者.
- 区分DLB和PCA之间的WMH模式,并将其与认知无障碍 (CU) 个体进行比较.
- 探索DLB和PCA之间WMH病理生理学的潜在差异.
主要方法:
- 招募了22名粉素阴性DLB患者,40名粉素阳性PCA患者和49名粉素阴性认知不受损 (CU) 个体.
- 使用3T头部MRI,匹兹堡化合物B (PiB) PET扫描和液体减弱反转恢复 (FLAIR) 序列.
- 分析了与诊断相关的区域WMH体积,根据年龄和性别进行调整.
主要成果:
- 与CU相比,DLB患者在叶,叶和额叶以及后体中表现出更大的周周结膜WMH.
- 与CU相比,PCA患者在叶,叶和叶中表现出较大的皮下WMH,在叶,叶和额叶中表现出较大的周周周WMH.
- 在比较DLB和PCA时,PCA在叶/叶中具有更多的皮下WMH,而DLB具有更多的后体结质WMH.
结论:
- DLB和PCA都与周周结膜性WMH相关.
- 深层皮层下WMH更为具有PCA的特征,而状WMH更为具有粉样阴性DLB的特征.
- 这些独特的WMH模式表明了DLB和PCA背后的不同病理生理机制.
相关概念视频
Dementia
83
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
83
Alzheimer's Disease: Overview
412
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
412


